Cargando…
STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
The cGAS STING pathway has received much attention in recent years, and it has been recognized as an important component of the innate immune response. Since the discovery of STING and that of cGAS, many observations based on preclinical models suggest that the faulty regulation of this pathway is i...
Autor principal: | Guerini, Danilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998017/ https://www.ncbi.nlm.nih.gov/pubmed/35406723 http://dx.doi.org/10.3390/cells11071159 |
Ejemplares similares
-
STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021) -
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
por: Manning, M, et al.
Publicado: (2012) -
Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
por: Cid-Jofré, Valeska, et al.
Publicado: (2021) -
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020) -
Potential Therapeutic Value of the STING Inhibitors
por: Zhang, Shangran, et al.
Publicado: (2023)